These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33045913)

  • 1. A direct comparison of women's perceptions and acceptability of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol in the management of young postmenopausal women, under 45 years of age.
    Mittal M; Panay N; Supramaniam PR; Savvas M; Cardozo L; Hamoda H
    Post Reprod Health; 2020 Dec; 26(4):210-219. PubMed ID: 33045913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial.
    Mittal M; McEniery C; Supramaniam PR; Cardozo L; Savvas M; Panay N; Hamoda H
    Maturitas; 2022 Jul; 161():18-26. PubMed ID: 35688490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy.
    Hirvonen E; Lamberg-Allardt C; Lankinen KS; Geurts P; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():19-25. PubMed ID: 9389779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
    Lübbert H; Nauert C
    Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trial.
    Mittal M; Chitongo P; Supramaniam PR; Cardozo L; Savvas M; Panay N; Arya R; Hamoda H
    Menopause; 2022 May; 29(5):580-589. PubMed ID: 35486948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
    Lindenfeld EA; Langer RD
    Obstet Gynecol; 2002 Nov; 100(5 Pt 1):853-63. PubMed ID: 12423841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms.
    Newson LR; Lass A
    Br J Gen Pract; 2018 Oct; 68(675):499-500. PubMed ID: 30262631
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.
    Cortellaro M; Nencioni T; Boschetti C; Ortolani S; Buzzi F; Francucci B; Caraceni MP; Abelli P; Polvani F; Zanussi C
    Eur J Clin Pharmacol; 1991; 41(6):555-9. PubMed ID: 1667755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
    Hirvonen E; Cacciatore B; Wahlström T; Rita H; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():26-31. PubMed ID: 9389780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.